Latest Regulatory Process News

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

NH3 Clean Energy has entered a pivotal phase in its WAH2 Project development, partnering with global engineering giant Linde and progressing funding discussions to secure up to A$567 million. This collaboration aims to reduce capital and operational risks as the project moves closer to a final investment decision.

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.

Sequoia Financial Group is actively reviewing its retail licensee services, focusing on its subsidiary InterPrac Financial Planning, with potential structural changes or a sale under consideration amid shifting platform provider relationships.

Arovella Therapeutics has secured TGA confirmation to advance its Phase 1 trial of ALA-101 in Australia via the efficient Clinical Trial Notification pathway, following FDA clearance in the US.

Peregrine Gold Limited has announced significant progress across its Pilbara projects, including new sampling programs targeting gold anomalies and approvals for drilling at key prospects. The company’s latest assays and heritage agreements set the stage for upcoming exploration activities.

Northern Minerals has withdrawn its Extraordinary General Meeting and obtained a court order to defer its 2025 AGM until June 30, 2026, allowing more time for regulatory review. This move supports progress toward a key investment decision for its Browns Range rare earths project.

Maronan Metals has been granted a Mineral Development Licence for its Maronan Silver Project, marking a pivotal step toward mine readiness and enabling underground resource expansion.

Caravel Minerals confirms its Definitive Feasibility Study for the Caravel Copper Project remains on track for mid-2026, while regulatory water investigations push the Final Investment Decision to late 2027. Meanwhile, strategic talks with Adani advance steadily.

A recent expert panel convened by Novitas has strongly endorsed Pacific Edge’s urine-based Cxbladder tests for hematuria evaluation, recommending Medicare coverage based on robust clinical evidence and patient care benefits.

3D Energi has announced two significant gas discoveries in the Otway Basin, validating its exploration models and advancing regulatory approvals. The company is now considering a follow-up well that could unlock further value in the region.